Brexit and the pharmaceutical sector
Together with the Ministry of Social Affairs and Health, other authorities and operators, Fimea has prepared for Brexit, i.e. withdrawal of the United Kingdom from the European Union.
Fimea and other pharmaceutical operators have mapped possible disturbances in the pharmaceutical services and the related risks. Cooperative measures have been initiated to prevent potential disruptions.
The situation picture is updated continually and efforts are continued in close cooperation to ensure uninterrupted patient treatment.